Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Administration, inhalation"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 296
Tytuł:
Inhaled Corticosteroids in Subjects with Chronic Obstructive Pulmonary Disease: An Old, Unfinished History.
Autorzy:
Melani AS; Respiratory Diseases Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, 53100 Siena, Italy.
Croce S; Respiratory Diseases Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, 53100 Siena, Italy.
Fabbri G; Respiratory Diseases Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, 53100 Siena, Italy.
Messina M; Respiratory Diseases Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, 53100 Siena, Italy.
Bargagli E; Respiratory Diseases Unit, Department of Medicine, Surgery and Neurosciences, University of Siena, 53100 Siena, Italy.
Pokaż więcej
Źródło:
Biomolecules [Biomolecules] 2024 Feb 06; Vol. 14 (2). Date of Electronic Publication: 2024 Feb 06.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Bronchodilator Agents*/adverse effects
Pulmonary Disease, Chronic Obstructive*/drug therapy
Humans ; Aged ; Adrenal Cortex Hormones/therapeutic use ; Administration, Inhalation ; Nebulizers and Vaporizers
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
[COPD - An Underestimated Disease].
Autorzy:
Leuppi JD; Universitäres Zentrum Innere Medizin, Kantonsspital Baselland, Liestal, Schweiz.; Medizinische Fakultät, Universität Basel, Basel, Schweiz.
Bridevaux PO; Service de pneumologie, Centre Hospitalier du Valais Romand, Hôpital du Valais, Sion, Schweiz.; Service de pneumologie, Hôpitaux Universitaires de Genève, Genf, Schweiz.; Faculty of medicine, University of Geneva, Genf, Schweiz.
Charbonnier F; Service de pneumologie, Hôpitaux Universitaires de Genève, Genf, Schweiz.
Clarenbach CF; Klinik für Pneumologie, Universitätsspital Zürich, Universität Zürich, Zürich, Schweiz.
Duchna HW; Hochgebirgsklinik Davos, Davos, Schweiz.
Fellrath JM; Service de Pneumologie, Département de médecine. Réseau Hospitalier Neuchâtelois; Neuchâtel, Schweiz.
Gianella P; Servizio di Pneumologia, Ospedale Regionale di Lugano, Lugano, Schweiz.
Jochmann A; Pädiatrische Pneumologie, Universitätskinderspital beider Basel, Basel, Schweiz.
Kern L; Klinik für Pneumologie und Schlafmedizin, Kantonsspital St. Gallen, St. Gallen, Schweiz.
Pavlov N; Universitätsklinik für Pneumologie, Inselspital, Universitätsspital Bern, Universität Bern, Bern, Schweiz.
Rothe T; Pneumologie/Schlafmedizin, Kantonsspital Graubünden, Chur, Schweiz.; Pneumologie, Spital Davos, Davos, Schweiz.
Steurer-Stey C; Institut für Epidemiologie, Biostatistik und Prävention, Universität Zürich, Zürich, Schweiz.; mediX Gruppenpraxis Zürich, Zürich, Schweiz.
von Garnier C; Service de Pneumologie, Centre Hospitalier Universitaire Vaudois, Université de Lausanne, Lausanne, Schweiz.
Pokaż więcej
Transliterated Title:
COPD – eine unterschätzte Erkrankung.
Źródło:
Praxis [Praxis (Bern 1994)] 2023 Jun; Vol. 112 (7-8), pp. 403-412.
Typ publikacji:
English Abstract; Journal Article
MeSH Terms:
Bronchodilator Agents*/therapeutic use
Pulmonary Disease, Chronic Obstructive*/therapy
Pulmonary Disease, Chronic Obstructive*/drug therapy
Humans ; Drug Therapy, Combination ; Administration, Inhalation ; Adrenergic beta-2 Receptor Agonists/therapeutic use ; Adrenal Cortex Hormones/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Efficacy of salmeterol and magnesium isoglycyrrhizinate combination treatment in rats with chronic obstructive pulmonary disease.
Autorzy:
Yang Y; Department of Pharmacology and Medicinal Chemistry, Jiangsu Vocational College of Medicine, Yancheng, 224005, Jiangsu, People's Republic of China.
Huang L; Department of Pharmacology and Medicinal Chemistry, Jiangsu Vocational College of Medicine, Yancheng, 224005, Jiangsu, People's Republic of China.
Tian C; Department of Pharmacology and Medicinal Chemistry, Jiangsu Vocational College of Medicine, Yancheng, 224005, Jiangsu, People's Republic of China.
Qian B; Department of Pharmacology and Medicinal Chemistry, Jiangsu Vocational College of Medicine, Yancheng, 224005, Jiangsu, People's Republic of China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Jul 19; Vol. 12 (1), pp. 12334. Date of Electronic Publication: 2022 Jul 19.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Bronchodilator Agents*/adverse effects
Pulmonary Disease, Chronic Obstructive*
Administration, Inhalation ; Albuterol/therapeutic use ; Androstadienes/pharmacology ; Animals ; Anti-Inflammatory Agents/therapeutic use ; Drug Combinations ; Fluticasone/pharmacology ; Fluticasone/therapeutic use ; Rats ; Salmeterol Xinafoate/pharmacology ; Salmeterol Xinafoate/therapeutic use ; Saponins ; Triterpenes
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Efficacy and safety of modified Bushen Yiqi formulas (MBYF) as an add-on to formoterol and budesonide in the management of COPD: study protocol for a multicentre, double-blind, placebo-controlled, parallel-group, randomized clinical trial: FB-MBYF Trial.
Autorzy:
Kong Q; Department of Integrative Medicine, Huashan Hospital, Fudan University, No. 12 Urumqi MIDDLE Road, Shanghai, 200040, China.; Institutes of Integrative Medicine, Fudan University, Shanghai, China.
Cao Y; Department of Integrative Medicine, Huashan Hospital, Fudan University, No. 12 Urumqi MIDDLE Road, Shanghai, 200040, China.; Institutes of Integrative Medicine, Fudan University, Shanghai, China.
Gao Z; Department of Integrative Medicine, Huashan Hospital, Fudan University, No. 12 Urumqi MIDDLE Road, Shanghai, 200040, China.; Institutes of Integrative Medicine, Fudan University, Shanghai, China.
Sun J; Department of Integrative Medicine, Huashan Hospital, Fudan University, No. 12 Urumqi MIDDLE Road, Shanghai, 200040, China.; Institutes of Integrative Medicine, Fudan University, Shanghai, China.
Zhang H; Department of Integrative Medicine, Huashan Hospital, Fudan University, No. 12 Urumqi MIDDLE Road, Shanghai, 200040, China.; Institutes of Integrative Medicine, Fudan University, Shanghai, China.
Du Y; Department of Integrative Medicine, Huashan Hospital, Fudan University, No. 12 Urumqi MIDDLE Road, Shanghai, 200040, China.; Institutes of Integrative Medicine, Fudan University, Shanghai, China.; Qingpu Traditional Chinese Medicine Hospital, Shanghai, China.
Lv Y; Department of Integrative Medicine, Huashan Hospital, Fudan University, No. 12 Urumqi MIDDLE Road, Shanghai, 200040, China.; Institutes of Integrative Medicine, Fudan University, Shanghai, China.
Zhou S; Department of Integrative Medicine, Huashan Hospital, Fudan University, No. 12 Urumqi MIDDLE Road, Shanghai, 200040, China.; Institutes of Integrative Medicine, Fudan University, Shanghai, China.
Tang Z; Department of Integrative Medicine, Huashan Hospital, Fudan University, No. 12 Urumqi MIDDLE Road, Shanghai, 200040, China.; Institutes of Integrative Medicine, Fudan University, Shanghai, China.
Liu B; Department of Integrative Medicine, Huashan Hospital, Fudan University, No. 12 Urumqi MIDDLE Road, Shanghai, 200040, China. .; Institutes of Integrative Medicine, Fudan University, Shanghai, China. .
Dong J; Department of Integrative Medicine, Huashan Hospital, Fudan University, No. 12 Urumqi MIDDLE Road, Shanghai, 200040, China. jingcheng_.; Institutes of Integrative Medicine, Fudan University, Shanghai, China. jingcheng_.
Pokaż więcej
Źródło:
Trials [Trials] 2022 Feb 14; Vol. 23 (1), pp. 143. Date of Electronic Publication: 2022 Feb 14.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Bronchodilator Agents*/adverse effects
Pulmonary Disease, Chronic Obstructive*/drug therapy
Administration, Inhalation ; Budesonide/adverse effects ; Double-Blind Method ; Drug Therapy, Combination/adverse effects ; Formoterol Fumarate/adverse effects ; Humans ; Multicenter Studies as Topic ; Prospective Studies ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Budesonide promotes airway epithelial barrier integrity following double-stranded RNA challenge.
Autorzy:
Rimmer C; Department of Medicine, Pulmonary and Critical Care, University of Rochester, Rochester, New York, United States of America.
Hetelekides S; Department of Medicine, Pulmonary and Critical Care, University of Rochester, Rochester, New York, United States of America.
Eliseeva SI; Department of Medicine, Pulmonary and Critical Care, University of Rochester, Rochester, New York, United States of America.
Georas SN; Department of Medicine, Pulmonary and Critical Care, University of Rochester, Rochester, New York, United States of America.; Department of Microbiology and Immunology, University of Rochester, Rochester, New York, United States of America.
Veazey JM; Department of Microbiology and Immunology, University of Rochester, Rochester, New York, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2021 Dec 06; Vol. 16 (12), pp. e0260706. Date of Electronic Publication: 2021 Dec 06 (Print Publication: 2021).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Asthma/*drug therapy
Bronchi/*drug effects
Bronchodilator Agents/*pharmacology
Budesonide/*pharmacology
Cell Membrane Permeability/*drug effects
Poly I-C/*antagonists & inhibitors
Acetates/pharmacology ; Administration, Inhalation ; Animals ; Asthma/chemically induced ; Asthma/metabolism ; Asthma/pathology ; Bronchi/metabolism ; Bronchi/pathology ; Cell Line ; Cyclopropanes/pharmacology ; Dextrans/metabolism ; Electric Impedance ; Epithelial Cells/cytology ; Epithelial Cells/drug effects ; Epithelial Cells/metabolism ; Female ; Fluorescein-5-isothiocyanate/analogs & derivatives ; Fluorescein-5-isothiocyanate/metabolism ; Formoterol Fumarate/pharmacology ; Humans ; Male ; Mice ; Mice, Inbred C57BL ; Models, Biological ; Molecular Mimicry ; Poly I-C/pharmacology ; Quinolines/pharmacology ; RNA, Double-Stranded/antagonists & inhibitors ; RNA, Double-Stranded/pharmacology ; RNA, Viral/antagonists & inhibitors ; RNA, Viral/pharmacology ; Sulfides/pharmacology ; Tight Junctions/drug effects ; Tight Junctions/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Short- and long-term effects of fluticasone furoate/vilanterol in exercising asthmatic adolescents: A randomized and open label trial.
Autorzy:
Bar-Yoseph R; Pediatric Pulmonary Institute, Ruth Children's Hospital, Rambam Health Care Campus, Haifa, Israel.; Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Gur M; Pediatric Pulmonary Institute, Ruth Children's Hospital, Rambam Health Care Campus, Haifa, Israel.; Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Zuckerman S; Department of Pediatrics, Ruth Children's Hospital, Rambam Health Care Campus, Haifa, Israel.
Gut G; Pediatric Pulmonary Institute, Ruth Children's Hospital, Rambam Health Care Campus, Haifa, Israel.
Hanna M; Pediatric Pulmonary Institute, Ruth Children's Hospital, Rambam Health Care Campus, Haifa, Israel.
Toukan Y; Pediatric Pulmonary Institute, Ruth Children's Hospital, Rambam Health Care Campus, Haifa, Israel.; Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Nir V; Pediatric Pulmonary Institute, Ruth Children's Hospital, Rambam Health Care Campus, Haifa, Israel.; Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Masarweh K; Pediatric Pulmonary Institute, Ruth Children's Hospital, Rambam Health Care Campus, Haifa, Israel.
Bentur L; Pediatric Pulmonary Institute, Ruth Children's Hospital, Rambam Health Care Campus, Haifa, Israel.; Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
Pokaż więcej
Źródło:
Basic & clinical pharmacology & toxicology [Basic Clin Pharmacol Toxicol] 2021 Nov; Vol. 129 (5), pp. 369-375. Date of Electronic Publication: 2021 Aug 25.
Typ publikacji:
Comparative Study; Journal Article; Randomized Controlled Trial
MeSH Terms:
Albuterol/*administration & dosage
Androstadienes/*administration & dosage
Asthma/*drug therapy
Benzyl Alcohols/*administration & dosage
Bronchodilator Agents/*administration & dosage
Chlorobenzenes/*administration & dosage
Administration, Inhalation ; Adolescent ; Albuterol/pharmacology ; Androstadienes/pharmacology ; Asthma/physiopathology ; Benzyl Alcohols/pharmacology ; Bronchodilator Agents/pharmacology ; Child ; Chlorobenzenes/pharmacology ; Double-Blind Method ; Drug Combinations ; Exercise Test ; Female ; Forced Expiratory Volume/drug effects ; Humans ; Male ; Nebulizers and Vaporizers ; Prospective Studies ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
A scintigraphy study of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in patients with moderate-to-very severe chronic obstructive pulmonary disease.
Autorzy:
Usmani O; Asthma Lab, National Heart and Lung Institute (NHLI), Imperial College London & Royal Brompton Hospital, South Block, Royal Brompton Campus, Sydney St, Chelsea, London, SW3 6NP, UK. .
Roche N; Respiratory Medicine, Hôpital Cochin (AP-HP), University of Paris, Cochin Institute, Paris, France.
Wahab E; Simbec Research Ltd, Merthyr Tydfil, UK.
Israel S; Simbec Research Ltd, Merthyr Tydfil, UK.
Jenkins M; AstraZeneca, Cambridge, UK.
Trivedi R; AstraZeneca, Durham, NC, USA.
Dorinsky P; AstraZeneca, Durham, NC, USA.
Aurivillius M; AstraZeneca, Gothenburg, Sweden.
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2021 Oct 07; Vol. 22 (1), pp. 261. Date of Electronic Publication: 2021 Oct 07.
Typ publikacji:
Clinical Trial, Phase I; Journal Article
MeSH Terms:
Adrenergic beta-2 Receptor Agonists*/administration & dosage
Adrenergic beta-2 Receptor Agonists*/adverse effects
Bronchodilator Agents*/administration & dosage
Bronchodilator Agents*/adverse effects
Glucocorticoids*/administration & dosage
Glucocorticoids*/adverse effects
Lung*/diagnostic imaging
Lung*/drug effects
Lung*/physiopathology
Muscarinic Antagonists*/administration & dosage
Muscarinic Antagonists*/adverse effects
Pulmonary Disease, Chronic Obstructive*/diagnostic imaging
Pulmonary Disease, Chronic Obstructive*/drug therapy
Pulmonary Disease, Chronic Obstructive*/physiopathology
Aged ; Female ; Humans ; Male ; Middle Aged ; Administration, Inhalation ; Contrast Media ; Metered Dose Inhalers ; Predictive Value of Tests ; Radionuclide Imaging ; Recovery of Function ; Severity of Illness Index ; Sodium Pertechnetate Tc 99m ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Optimal administration of bronchodilators with valved holding chambers in preschool children: a review of literature.
Autorzy:
Csonka P; Centre for Child Health Research, Tampere University and Tampere University Hospital, Kalevantie 4, 33014 Tampereen yliopisto, Tampere, Finland. .; Terveystalo Healthcare, Tampere, Finland. .
Tapiainen T; Department of Pediatrics and Adolescent Medicine, Oulu University Hospital and PEDEGO Research Unit, University of Oulu, Oulu, Finland.
Mäkelä MJ; Skin and Allergy Hospital, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Lehtimäki L; Allergy Centre, Tampere University Hospital, Tampere, Finland.; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Pokaż więcej
Źródło:
European journal of pediatrics [Eur J Pediatr] 2021 Oct; Vol. 180 (10), pp. 3101-3109. Date of Electronic Publication: 2021 Apr 20.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Bronchodilator Agents*
Inhalation Spacers*
Administration, Inhalation ; Aerosols ; Child, Preschool ; Equipment Design ; Humans ; Metered Dose Inhalers
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Single-inhaler triple vs single-inhaler dual therapy in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized control trials.
Autorzy:
Long H; Department of Respiratory and Critical Care Medicine, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.; The Key Laboratory of Geriatrics, Beijing Institute of Geriatrics, Beijing Hospital, National Center of Gerontology, National Health Commission; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Xu H; The Key Laboratory of Geriatrics, Beijing Institute of Geriatrics, Beijing Hospital, National Center of Gerontology, National Health Commission; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.; Department of Cardiology, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Janssens JP; Division of Pulmonary Diseases, Department of Medicine, Geneva University Hospitals, Geneva, Switzerland.
Guo Y; Department of Respiratory and Critical Care Medicine, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China. .
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2021 Jul 23; Vol. 22 (1), pp. 209. Date of Electronic Publication: 2021 Jul 23.
Typ publikacji:
Comparative Study; Journal Article; Meta-Analysis; Systematic Review
MeSH Terms:
Bronchodilator Agents/*administration & dosage
Nebulizers and Vaporizers/*trends
Pulmonary Disease, Chronic Obstructive/*drug therapy
Pulmonary Disease, Chronic Obstructive/*mortality
Randomized Controlled Trials as Topic/*methods
Administration, Inhalation ; Drug Therapy, Combination ; Humans ; Mortality/trends ; Pulmonary Disease, Chronic Obstructive/diagnosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Efficacy and safety of inhaled nitric oxide in the treatment of severe/critical COVID-19 patients: A systematic review.
Autorzy:
Prakash A; Department of Pharmacology, Experimental Pharmacology Laboratory, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Kaur S; Department of Pharmacology, Experimental Pharmacology Laboratory, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Kaur C; Department of Pharmacology, Experimental Pharmacology Laboratory, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Prabha PK; Department of Pharmacology, Experimental Pharmacology Laboratory, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Bhatacharya A; Department of Ophthalmology, GMCH, Chandigarh, India.
Sarma P; Department of Pharmacology, Experimental Pharmacology Laboratory, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Medhi B; Department of Pharmacology, Experimental Pharmacology Laboratory, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Pokaż więcej
Źródło:
Indian journal of pharmacology [Indian J Pharmacol] 2021 May-Jun; Vol. 53 (3), pp. 236-243.
Typ publikacji:
Journal Article; Systematic Review
MeSH Terms:
Severity of Illness Index*
COVID-19 Drug Treatment*
Bronchodilator Agents/*administration & dosage
Critical Illness/*therapy
Nitric Oxide/*administration & dosage
Administration, Inhalation ; COVID-19/diagnosis ; COVID-19/mortality ; Humans ; Respiration, Artificial/trends ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Efficacy and safety of single-inhaler extrafine triple therapy versus inhaled corticosteroid plus long-acting beta2 agonist in eastern Asian patients with COPD: the TRIVERSYTI randomised controlled trial.
Autorzy:
Zheng J; State Key Laboratory of Respiratory Disease, National Clinical Research Centre for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Baldi S; Global Clinical Development, Chiesi Farmaceutici SpA, Largo Belloli, 11\a, 43122, Parma, Italy.
Zhao L; Shengjing Hospital of China Medical University, Shenyang, China.
Li H; Shanghai Pulmonary Hospital, Shanghai, China.
Lee KH; Yeungnam University Medical Center, Daegu, Republic of Korea.
Singh D; Medicines Evaluation Unit, The University of Manchester, Manchester University NHS Foundations Trust, Manchester, UK.
Papi A; Respiratory Medicine Unit, University of Ferrara, University Hospital S. Anna, Ferrara, Italy.
Grapin F; Global Clinical Development, Chiesi Farmaceutici SpA, Largo Belloli, 11\a, 43122, Parma, Italy.
Guasconi A; Global Clinical Development, Chiesi Farmaceutici SpA, Largo Belloli, 11\a, 43122, Parma, Italy.
Georges G; Global Clinical Development, Chiesi Farmaceutici SpA, Largo Belloli, 11\a, 43122, Parma, Italy. .
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2021 Mar 23; Vol. 22 (1), pp. 90. Date of Electronic Publication: 2021 Mar 23.
Typ publikacji:
Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:
Adrenergic beta-2 Receptor Agonists/*administration & dosage
Beclomethasone/*administration & dosage
Bronchodilator Agents/*administration & dosage
Formoterol Fumarate/*administration & dosage
Glucocorticoids/*administration & dosage
Glycopyrrolate/*administration & dosage
Lung/*drug effects
Muscarinic Antagonists/*administration & dosage
Pulmonary Disease, Chronic Obstructive/*drug therapy
Administration, Inhalation ; Adrenergic beta-2 Receptor Agonists/adverse effects ; Aged ; Beclomethasone/adverse effects ; Bronchodilator Agents/adverse effects ; China ; Disease Progression ; Double-Blind Method ; Drug Combinations ; Dry Powder Inhalers ; Female ; Forced Expiratory Volume ; Formoterol Fumarate/adverse effects ; Glucocorticoids/adverse effects ; Glycopyrrolate/adverse effects ; Humans ; Lung/physiopathology ; Male ; Middle Aged ; Muscarinic Antagonists/adverse effects ; Pulmonary Disease, Chronic Obstructive/diagnosis ; Pulmonary Disease, Chronic Obstructive/physiopathology ; Recovery of Function ; Republic of Korea ; Taiwan ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Influence of government-driven quality assessment program on patients with chronic obstructive pulmonary disease.
Autorzy:
Park HJ; Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
Kim SR; Division of Allergy and Immunology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.; Institute of Allergy, Yonsei University College of Medicine, Seoul, Republic of Korea.
Kim S; Division of Biostatistics, Department of R&D Management, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Lee HS; Biostatistics Collaboration Unit, Yonsei University College of Medicine, Seoul, Republic of Korea.
Kim BY; Healthcare Insurance Review and Assessment Service, Wonju, Republic of Korea.
Kim HK; Healthcare Insurance Review and Assessment Service, Wonju, Republic of Korea.
Ahn SI; Healthcare Insurance Review and Assessment Service, Wonju, Republic of Korea.
Shin JH; Healthcare Insurance Review and Assessment Service, Wonju, Republic of Korea.
Lee JH; Division of Allergy and Immunology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea. .; Institute of Allergy, Yonsei University College of Medicine, Seoul, Republic of Korea. .
Park JW; Division of Allergy and Immunology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.; Institute of Allergy, Yonsei University College of Medicine, Seoul, Republic of Korea.
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2021 Mar 21; Vol. 22 (1), pp. 87. Date of Electronic Publication: 2021 Mar 21.
Typ publikacji:
Comparative Study; Journal Article
MeSH Terms:
Bronchodilator Agents/*administration & dosage
Lung/*drug effects
National Health Programs/*standards
Pulmonary Disease, Chronic Obstructive/*drug therapy
Quality Assurance, Health Care/*standards
Quality Improvement/*standards
Quality Indicators, Health Care/*standards
Administration, Inhalation ; Aged ; Aged, 80 and over ; Drug Prescriptions ; Drug Utilization/standards ; Female ; Government Regulation ; Humans ; Lung/physiopathology ; Male ; Middle Aged ; Practice Patterns, Physicians'/standards ; Program Evaluation ; Pulmonary Disease, Chronic Obstructive/diagnosis ; Pulmonary Disease, Chronic Obstructive/mortality ; Pulmonary Disease, Chronic Obstructive/physiopathology ; Republic of Korea/epidemiology ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
The Role of ICS/LABA Fixed-Dose Combinations in the Treatment of Asthma and COPD: Bioequivalence of a Generic Fluticasone Propionate-Salmeterol Device.
Autorzy:
Tashkin DP; Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
Ohar JA; Department of Internal Medicine, Section of Pulmonary, Critical Care, Allergy and Immunologic Medicine at Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Koltun A; Viatris/Mylan Inc., Canonsburg, PA, USA.
Allan R; Viatris/Mylan Pharma UK Ltd., UK.
Ward JK; Viatris/Mylan Pharma UK Ltd., UK.
Pokaż więcej
Źródło:
Pulmonary medicine [Pulm Med] 2021 Mar 17; Vol. 2021, pp. 8881895. Date of Electronic Publication: 2021 Mar 17 (Print Publication: 2021).
Typ publikacji:
Journal Article; Review
MeSH Terms:
Asthma*/drug therapy
Asthma*/epidemiology
Asthma*/physiopathology
Bronchodilator Agents*/pharmacokinetics
Bronchodilator Agents*/therapeutic use
Fluticasone-Salmeterol Drug Combination*/pharmacokinetics
Fluticasone-Salmeterol Drug Combination*/therapeutic use
Glucocorticoids*/pharmacokinetics
Glucocorticoids*/therapeutic use
Pulmonary Disease, Chronic Obstructive*/drug therapy
Pulmonary Disease, Chronic Obstructive*/epidemiology
Pulmonary Disease, Chronic Obstructive*/physiopathology
Administration, Inhalation ; Drugs, Generic/pharmacokinetics ; Drugs, Generic/therapeutic use ; Health Services Needs and Demand/statistics & numerical data ; Humans ; Nebulizers and Vaporizers ; Powders/pharmacokinetics ; Powders/therapeutic use ; Practice Guidelines as Topic ; Standard of Care ; Therapeutic Equivalency
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Aerosol drug delivery to spontaneously-breathing preterm neonates: lessons learned.
Autorzy:
Bianco F; Department of Preclinical Pharmacology, R&D, Chiesi Farmaceutici S.P.A., 43122, Parma, Italy. .
Salomone F; Department of Preclinical Pharmacology, R&D, Chiesi Farmaceutici S.P.A., 43122, Parma, Italy.
Milesi I; Department of Preclinical Pharmacology, R&D, Chiesi Farmaceutici S.P.A., 43122, Parma, Italy.
Murgia X; Scientific Consultant, 48640, Bilbao, Spain.
Bonelli S; Department of Preclinical Pharmacology, R&D, Chiesi Farmaceutici S.P.A., 43122, Parma, Italy.
Pasini E; Department of Preclinical Pharmacology, R&D, Chiesi Farmaceutici S.P.A., 43122, Parma, Italy.
Dellacà R; TechRes Lab, Dipartimento Di Elettronica, Informazione E Bioingegneria (DEIB), Politecnico Di Milano University, Milano, Italy.
Ventura ML; Neonatal Intensive Care Unit, Fondazione MBBM-ASST-Monza, Monza, Italy.
Pillow J; School of Human Sciences, University of Western Australia, Perth, Australia.
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2021 Feb 26; Vol. 22 (1), pp. 71. Date of Electronic Publication: 2021 Feb 26.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Nebulizers and Vaporizers*
Bronchodilator Agents/*administration & dosage
Drug Delivery Systems/*methods
Noninvasive Ventilation/*methods
Premature Birth/*drug therapy
Respiratory Mechanics/*drug effects
Administration, Inhalation ; Aerosols ; Drug Delivery Systems/instrumentation ; Humans ; Infant, Newborn ; Noninvasive Ventilation/instrumentation ; Premature Birth/diagnosis ; Premature Birth/physiopathology ; Respiratory Mechanics/physiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
The novel TRPA1 antagonist BI01305834 inhibits ovalbumin-induced bronchoconstriction in guinea pigs.
Autorzy:
van den Berg MPM; Department of Molecular Pharmacology, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands.; Groningen Research Institute for Asthma and COPD (GRIAC), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Nijboer-Brinksma S; Department of Molecular Pharmacology, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands.; Groningen Research Institute for Asthma and COPD (GRIAC), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Bos IST; Department of Molecular Pharmacology, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands.; Groningen Research Institute for Asthma and COPD (GRIAC), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
van den Berge M; Groningen Research Institute for Asthma and COPD (GRIAC), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Department of Pulmonary Diseases, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Lamb D; Immunology + Respiratory, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany.
van Faassen M; Department of Laboratory Medicine, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
Kema IP; Department of Laboratory Medicine, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
Gosens R; Department of Molecular Pharmacology, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands.; Groningen Research Institute for Asthma and COPD (GRIAC), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Kistemaker LEM; Department of Molecular Pharmacology, University of Groningen, Antonius Deusinglaan 1, 9713 AV, Groningen, The Netherlands. .; Groningen Research Institute for Asthma and COPD (GRIAC), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. .
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2021 Feb 08; Vol. 22 (1), pp. 48. Date of Electronic Publication: 2021 Feb 08.
Typ publikacji:
Journal Article
MeSH Terms:
Asthma/*drug therapy
Bronchoconstriction/*physiology
Bronchodilator Agents/*administration & dosage
Lung/*physiology
Ovalbumin/*toxicity
TRPA1 Cation Channel/*antagonists & inhibitors
Administration, Inhalation ; Animals ; Asthma/chemically induced ; Asthma/physiopathology ; Bronchoconstriction/drug effects ; Dose-Response Relationship, Drug ; Guinea Pigs ; Humans ; Lung/drug effects ; Male ; Organ Culture Techniques ; Pilot Projects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Status of metered dose inhaler technique among patients with asthma and its effect on asthma control in Northwest Ethiopia.
Autorzy:
Mebrahtom M; Department of Internal Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Mesfin N; Department of Internal Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Gebreyesus H; College of Health Science, Aksum University, P.O. Box 298, Aksum, Tigray, Ethiopia.
Teweldemedhin M; College of Health Science, Aksum University, P.O. Box 298, Aksum, Tigray, Ethiopia. .
Pokaż więcej
Źródło:
BMC research notes [BMC Res Notes] 2019 Jan 14; Vol. 12 (1), pp. 15. Date of Electronic Publication: 2019 Jan 14.
Typ publikacji:
Journal Article
MeSH Terms:
Administration, Inhalation*
Metered Dose Inhalers*
Asthma/*drug therapy
Bronchodilator Agents/*administration & dosage
Adolescent ; Adult ; Cross-Sectional Studies ; Ethiopia ; Female ; Humans ; Male ; Middle Aged ; Patient Education as Topic ; Self Administration ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: observational comparative effectiveness study.
Autorzy:
Magnussen H; Pulmonary Research Institute at Lung Clinic Grosshansdorf, Airway Research Center North, Member of the German Center of Lung Research, Grosshansdorf, Germany.
Lucas S; Respiratory Effectiveness Group, Ely, UK.
Lapperre T; Department of Respiratory Medicine, Antwerp University Hospital, Edegem, Denmark.; Laboratory of Experimental Medicine and Paediatrics, University of Antwerp, Wilrijk, UK.
Quint JK; Laboratory of Experimental Medicine and Paediatrics, University of Antwerp, Wilrijk, UK.
Dandurand RJ; CIUSSS de L'Ouest-de-L'Île-de-Montréal, Montreal Chest Institute, Meakins-Christie Laboratories, Oscillometry Unit and Centre for Innovative Medicine, McGill University Health Centre and Research Institute, Montreal, QC, Canada.
Roche N; Department of Respiratory Medicine, APHP-Centre University of Paris, UMR1016, Cochin Institute, Paris, France.
Papi A; Section of Cardiorespiratory and Internal Medicine, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.
Price D; Observational and Pragmatic Research Institute, Singapore, Singapore.; Centre of Academic Primary Care, Division of Applied Health Sciences, University of Aberdeen, Aberdeen, UK.
Miravitlles M; Pneumology Department, Hospital Universitari Vall D'Hebron, Vall D'Hebron Institut de Recerca (VHIR), CIBER de Enfermedades Respiratorias (CIBERES), Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain. .
Pokaż więcej
Corporate Authors:
Respiratory Effectiveness Group (REG)
Źródło:
Respiratory research [Respir Res] 2021 Jan 21; Vol. 22 (1), pp. 25. Date of Electronic Publication: 2021 Jan 21.
Typ publikacji:
Comparative Study; Journal Article; Observational Study
MeSH Terms:
Adrenal Cortex Hormones/*administration & dosage
Adrenal Cortex Hormones/*adverse effects
Bronchodilator Agents/*administration & dosage
Pulmonary Disease, Chronic Obstructive/*diagnosis
Pulmonary Disease, Chronic Obstructive/*drug therapy
Safety-Based Drug Withdrawals/*trends
Administration, Inhalation ; Aged ; Aged, 80 and over ; Female ; Humans ; Male ; Middle Aged ; Pulmonary Disease, Chronic Obstructive/epidemiology ; Treatment Outcome ; United Kingdom/epidemiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Evaluating the association of osteoporosis with inhaled corticosteroid use in chronic obstructive pulmonary disease in Taiwan.
Autorzy:
Chiu KL; Master Program in Clinical Pharmacy, School of Pharmacy, Kaohsiung Medical University, No. 100, Shihcyuan 1st Rd., Sanmin District, Kaohsiung, 80708, Taiwan, ROC.; Department of Pharmacy, Kaohsiung Medical University Hospital, No. 100, Tzyou 1st Rd., Sanmin District, Kaohsiung, 80708, Taiwan, ROC.
Lee CC; Department of Pharmacy, Kaohsiung Medical University Hospital, No. 100, Tzyou 1st Rd., Sanmin District, Kaohsiung, 80708, Taiwan, ROC. .
Chen CY; Master Program in Clinical Pharmacy, School of Pharmacy, Kaohsiung Medical University, No. 100, Shihcyuan 1st Rd., Sanmin District, Kaohsiung, 80708, Taiwan, ROC. .; Department of Pharmacy, Kaohsiung Medical University Hospital, No. 100, Tzyou 1st Rd., Sanmin District, Kaohsiung, 80708, Taiwan, ROC. .; Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan. .; Center for Big Data Research, Kaohsiung Medical University, Kaohsiung, Taiwan. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Jan 12; Vol. 11 (1), pp. 724. Date of Electronic Publication: 2021 Jan 12.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Adrenal Cortex Hormones/*adverse effects
Bronchodilator Agents/*adverse effects
Osteoporosis/*epidemiology
Pulmonary Disease, Chronic Obstructive/*drug therapy
Administration, Inhalation ; Adrenal Cortex Hormones/administration & dosage ; Adult ; Aged ; Aged, 80 and over ; Bronchodilator Agents/administration & dosage ; Case-Control Studies ; Cohort Studies ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Osteoporosis/chemically induced ; Osteoporosis/pathology ; Prognosis ; Pulmonary Disease, Chronic Obstructive/pathology ; Risk Factors ; Taiwan/epidemiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The TRIFLOW study: a randomised, cross-over study evaluating the effects of extrafine beclometasone/formoterol/glycopyrronium on gas trapping in COPD.
Autorzy:
Dean J; Medicines Evaluation Unit, Southmoor Road, Manchester, M23 9QZ, UK. .
Panainte C; Medicines Evaluation Unit, Southmoor Road, Manchester, M23 9QZ, UK.
Khan N; Medicines Evaluation Unit, Southmoor Road, Manchester, M23 9QZ, UK.
Singh D; Medicines Evaluation Unit, Southmoor Road, Manchester, M23 9QZ, UK.; Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester and Manchester University NHS Foundation Trust, Manchester, UK.
Pokaż więcej
Źródło:
Respiratory research [Respir Res] 2020 Dec 09; Vol. 21 (1), pp. 323. Date of Electronic Publication: 2020 Dec 09.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Adrenergic beta-2 Receptor Agonists/*administration & dosage
Beclomethasone/*administration & dosage
Bronchodilator Agents/*administration & dosage
Formoterol Fumarate/*administration & dosage
Glucocorticoids/*administration & dosage
Glycopyrrolate/*administration & dosage
Lung/*drug effects
Muscarinic Antagonists/*administration & dosage
Pulmonary Disease, Chronic Obstructive/*drug therapy
Administration, Inhalation ; Adrenergic beta-2 Receptor Agonists/adverse effects ; Adult ; Aged ; Beclomethasone/adverse effects ; Bronchodilator Agents/adverse effects ; Cross-Over Studies ; Drug Combinations ; England ; Female ; Forced Expiratory Volume ; Formoterol Fumarate/adverse effects ; Glucocorticoids/adverse effects ; Glycopyrrolate/adverse effects ; Humans ; Lung/physiopathology ; Male ; Middle Aged ; Muscarinic Antagonists/adverse effects ; Nebulizers and Vaporizers ; Particle Size ; Pulmonary Disease, Chronic Obstructive/diagnosis ; Pulmonary Disease, Chronic Obstructive/physiopathology ; Recovery of Function ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
A cautionary tale of multiple-dose drug products: Fluticasone and salmeterol combination inhaler waste.
Autorzy:
Aeng ESY; Pharmacy Department, Fraser Health Authority, Surrey, British Columbia, Canada.
Dhaliwal MM; Pharmacy Department, Fraser Health Authority, Surrey, British Columbia, Canada.
Tejani AM; Pharmacy Department, Fraser Health Authority, Surrey, British Columbia, Canada.
Pokaż więcej
Źródło:
Journal of evaluation in clinical practice [J Eval Clin Pract] 2020 Dec; Vol. 26 (6), pp. 1699-1702. Date of Electronic Publication: 2020 Feb 12.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Asthma*/drug therapy
Bronchodilator Agents*/therapeutic use
Fluticasone*/therapeutic use
Salmeterol Xinafoate*/therapeutic use
Administration, Inhalation ; Canada ; Drug Combinations ; Humans ; Nebulizers and Vaporizers ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 296

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies